A baseline resting heart rate of 90 bpm going to 96 bpm is a different situation than 60 bpm going to 66 bpm
Food and Drug Administration (FDA) - "Saxenda (Liraglutide) Injection, for Subcutaneous Use." Accessed on April 3, 2024, at FDA - "Drug Compounding and Drug Shortages." Accessed on April 3, 2024, at Harvard T.H
While retatrutide itself is not controlled at the federal level, individual state laws can create additional requirements or restrictions
Eli Lilly and Company, and Novo Nordisk are key players in GLP-1 agonists market
If youre interested in learning more about tirzepatide or exploring your options for medical weight management, contact En Vogue IV Therapy & Wellness today to schedule your personalized consultation
Theyre meant to be used, along with lifestyle changes such as diet and exercise, under a health care providers supervision